Hinge Health, Inc. (HNGE) Fair Value & Analysis
Healthcare · US · Market cap $6.9B · ISIN US4333131039
What is Hinge Health, Inc. really worth?
Hinge Health, Inc.
HNGE · US
A solid business, but trading 278% above our fair value of $24.03.
Strengths
Risks
Fair value as of: Aug 13, 2026
From 7 valuation models · updated 22 days ago
Share price +14.3% over the past month.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
What matters now
- The price sits above even our optimistic bull case ($30.51). The favourable scenario is already priced in.
- The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution.
- Solid but not exceptional quality (65/100) and above fair value, neither a clear bargain nor a standout compounder.
Price vs Fair Value (15 months)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 13, 2026.
How to read this chart
15‑month range $31.17 – $92.85 · fair‑value band $17.56 – $30.51 · the $90.76 price screens above the $24.03 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Aug 13, 2026.
Analysis
Hinge Health, Inc. (HNGE) currently trades at $90.76, while our model-based Fair Value estimate is $24.03, implying the stock looks roughly 277.6% overvalued today. The Quality Score stands at 65/100 (solid quality), in the Healthcare sector. Bull case: the DCF Models group reads highest at a median of $52.47 per share, and 0 of the 7 models we run sit above the $90.76 price. Bear case: the Asset-Based group reads lowest at $3.10, and 7 of the 7 models stay below the price. Evidence for this calculation is low.
Over the trailing twelve months, Hinge Health, Inc. generated revenue of $646M at a net margin of −79.0%. Revenue grew 47.2% year over year. The balance sheet holds a net cash position of $200M. Fundamentals as of Aug 13, 2026
Our scenario range runs from $17.56 (bear case) to $30.51 (bull case); at $90.76, the current price sits above that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades near its 52-week high and 202% above its 52-week low, currently above its 200-day average. For context, the median of 10 Healthcare peers we cover trades at −64% fair-value upside, at −74%, HNGE screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted, family-balanced blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small. Every input is real reported data, nothing guessed.
All 7 models by family
Widest divergence: DCF Models ($52.47) versus Asset-Based ($3.10). Highest evidence: FCF DCF (64).
Notify me when HNGE reaches fair value
Put HNGE on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.
Set up alert →Free, no payment details. Unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 13, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 69 · Market factors (momentum, volatility) 71
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
All values are scores from 0 to 100 (100 = best against fixed, research-based bands), not percentages. The three market factors (momentum, 52-week proximity, low volatility) are displayed but carry zero weight in the headline number: market sentiment is not a business property.
About the company
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation.
Full company description
Hinge Health, Inc. focuses on building a health system that scales and automates the delivery of care using technology. It designs its platform to address musculoskeletal system care (MSK), including acute injury, chronic pain, and post-surgical rehabilitation. The company also provides personalized and automated MSK care through AI-powered motion tracking technology and a proprietary electrical nerve stimulation wearable device. It primarily serves self-insured employers. The company was founded in 2012 and is headquartered in San Francisco, California.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2023 – FY2025 · reported fiscal years
Hinge Health, Inc. reported revenue of $588M in FY2025 versus $293M in FY2023, a compound +41.7%/yr. Reported net income was −$528M in FY2025.
HNGE screens 278% overvalued. Compare with Veeva Systems Inc →
Recent news
External third-party headlines (Yahoo Finance, Reuters and others), not an editorial selection.
- Could Hinge Health (HNGE) Stock Win as Digital Healthcare Expands Beyond MSK Care?
- Hinge Health Catapults 95%; Expands Footprint In AI Pain Management
- HNGE Stock Surges Nearly 90% YTD: Can Its Growth Story Continue?
- Reasons to Hold Hinge Health Stock in Your Portfolio for Now
Peer Group
Health Information Services · 128 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Health Information Services median · lower = cheaper
Strength profile in five axes (Snowflake)
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
VALUE 0: the price sits above our fair-value range.
Insider activity: 42/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Health Information Services stocks, each showing price versus our Fair Value estimate (as of Aug 13, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Veeva Systems Inc VEEV | $282.13 | $91.49 | −68% |
| Pro Medicus Limited PME | A$183.71 | A$23.74 | −87% |
| BrightSpring Health Services, Inc BTSG | $59.68 | $21.31 | −64% |
| HealthEquity, Inc HQY | $104.27 | $56.63 | −46% |
| 10x Genomics, Inc TXG | $55.63 | $17.18 | −69% |
| Waystar Holding WAY | $25.76 | $12.86 | −50% |
| XtalPi Holdings 2228 | HK$8.19 | HK$1.04 | −87% |
| Doximity, Inc DOCS | $24.74 | $25.91 | +5% |
| Privia Health Group PRVA | $21.07 | $5.26 | −75% |
| IKS IKS | ₹1,785 | ₹830.74 | −53% |
Compare Hinge Health, Inc. with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Hinge Health, Inc. (HNGE) overvalued or undervalued?
What is the fair value of HNGE?
What is the quality score of HNGE?
What is the revenue of Hinge Health, Inc. (HNGE)?
What is the net profit margin of HNGE?
Watch Hinge Health, Inc. in the live analysis
One click puts Hinge Health, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.